300 related articles for article (PubMed ID: 36549296)
41. Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial.
Hallsworth K; Thoma C; Hollingsworth KG; Cassidy S; Anstee QM; Day CP; Trenell MI
Clin Sci (Lond); 2015 Dec; 129(12):1097-105. PubMed ID: 26265792
[TBL] [Abstract][Full Text] [Related]
42. Effects of weight loss via high fat vs. low fat alternate day fasting diets on free fatty acid profiles.
Varady KA; Dam VT; Klempel MC; Horne M; Cruz R; Kroeger CM; Santosa S
Sci Rep; 2015 Jan; 5():7561. PubMed ID: 25557754
[TBL] [Abstract][Full Text] [Related]
43. Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans.
Bhutani S; Klempel MC; Kroeger CM; Trepanowski JF; Varady KA
Obesity (Silver Spring); 2013 Jul; 21(7):1370-9. PubMed ID: 23408502
[TBL] [Abstract][Full Text] [Related]
44. Effect of Intermittent Fasting on Lipid Profile, Anthropometric and Hepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review.
Castillo MF; Salgado-Canales D; Arrese M; Barrera F; Mikhailidis DP
Curr Vasc Pharmacol; 2024 Jan; ():. PubMed ID: 38321893
[TBL] [Abstract][Full Text] [Related]
45. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
Daneshi-Maskooni M; Keshavarz SA; Mansouri S; Qorbani M; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
Trials; 2017 Jun; 18(1):260. PubMed ID: 28592311
[TBL] [Abstract][Full Text] [Related]
46. Contribution of Liver Fat to Weight Loss-Induced Changes in Serum Hepatokines: A Randomized Controlled Trial.
Telgenkamp I; Kusters YHAM; Schalkwijk CG; Houben AJHM; Kooi ME; Lindeboom L; Bons JAP; Schaper NC; Joris PJ; Plat J; Mensink RP; Stehouwer CDA; Brouwers MCGJ
J Clin Endocrinol Metab; 2019 Jul; 104(7):2719-2727. PubMed ID: 30753672
[TBL] [Abstract][Full Text] [Related]
47. Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: A systematic review and meta-analysis.
Lange M; Nadkarni D; Martin L; Newberry C; Kumar S; Kushner T
Hepatol Commun; 2023 Aug; 7(8):. PubMed ID: 37534936
[TBL] [Abstract][Full Text] [Related]
48. [Effect of aerobic exercise on AKT/GSK3β mediated hepatocyte apoptosis in nonalcoholic fatty liver disease].
Wang J; Li Y; Jiang C; Li J
Wei Sheng Yan Jiu; 2023 Mar; 52(2):246-252. PubMed ID: 37062687
[TBL] [Abstract][Full Text] [Related]
49. Effects of sprint interval training on ectopic lipids and tissue-specific insulin sensitivity in men with non-alcoholic fatty liver disease.
Sargeant JA; Bawden S; Aithal GP; Simpson EJ; Macdonald IA; Turner MC; Cegielski J; Smith K; Dorling JL; Gowland PA; Nimmo MA; King JA
Eur J Appl Physiol; 2018 Apr; 118(4):817-828. PubMed ID: 29411128
[TBL] [Abstract][Full Text] [Related]
50. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
[TBL] [Abstract][Full Text] [Related]
51. Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
Panahi Y; Ghamarchehreh ME; Beiraghdar F; Zare R; Jalalian HR; Sahebkar A
Hepatogastroenterology; 2012 Oct; 59(119):2099-2103. PubMed ID: 23234816
[TBL] [Abstract][Full Text] [Related]
52. Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: A randomized controlled trial.
Kord Varkaneh H; Salehi Sahlabadi A; Găman MA; Rajabnia M; Sedanur Macit-Çelebi M; Santos HO; Hekmatdoost A
Front Nutr; 2022; 9():948655. PubMed ID: 35958257
[TBL] [Abstract][Full Text] [Related]
53. Effect of aerobic exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver disease in postmenopausal women and middle aged men--the role of gut microbiota composition: study protocol for the AELC randomized controlled trial.
Liu WY; Lu DJ; Du XM; Sun JQ; Ge J; Wang RW; Wang R; Zou J; Xu C; Ren J; Wen XF; Liu Y; Cheng SM; Tan X; Pekkala S; Munukka E; Wiklund P; Chen YQ; Gu Q; Xia ZC; Liu JJ; Liu WB; Chen XB; Zhang YM; Li R; Borra RJ; Yao JX; Chen PJ; Cheng S
BMC Public Health; 2014 Jan; 14():48. PubMed ID: 24438438
[TBL] [Abstract][Full Text] [Related]
54. Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial.
Varady KA; Bhutani S; Klempel MC; Kroeger CM; Trepanowski JF; Haus JM; Hoddy KK; Calvo Y
Nutr J; 2013 Nov; 12(1):146. PubMed ID: 24215592
[TBL] [Abstract][Full Text] [Related]
55. [Study on the correlation between type 2 diabetes mellitus combined with non-alcoholic steatohepatitis and aerobic exercise performance].
Zhang J; Li L; Yu HY; Li Y; Wang FM; Di FS
Zhonghua Gan Zang Bing Za Zhi; 2023 Oct; 31(10):1068-1074. PubMed ID: 38016772
[No Abstract] [Full Text] [Related]
56. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.
Smith GI; Shankaran M; Yoshino M; Schweitzer GG; Chondronikola M; Beals JW; Okunade AL; Patterson BW; Nyangau E; Field T; Sirlin CB; Talukdar S; Hellerstein MK; Klein S
J Clin Invest; 2020 Mar; 130(3):1453-1460. PubMed ID: 31805015
[TBL] [Abstract][Full Text] [Related]
57. Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C--a randomized trial.
Rusu E; Jinga M; Enache G; Rusu F; Dragomir AD; Ancuta I; Draguţ R; Parpala C; Nan R; Sima I; Ateia S; Stoica V; Cheţa DM; Radulian G
Nutr J; 2013 Aug; 12():119. PubMed ID: 23941362
[TBL] [Abstract][Full Text] [Related]
58. The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
Alami F; Alizadeh M; Shateri K
Scand J Gastroenterol; 2022 Oct; 57(10):1238-1249. PubMed ID: 35710164
[TBL] [Abstract][Full Text] [Related]
59. Effect of 5:2 Fasting Diet on Liver Fat Content in Patients with Type 2 Diabetic with Nonalcoholic Fatty Liver Disease.
Xiao Y; Liu Y; Zhao L; Zhou Y
Metab Syndr Relat Disord; 2022 Oct; 20(8):459-465. PubMed ID: 35925752
[No Abstract] [Full Text] [Related]
60. Lifestyle Intervention Enabled by Mobile Technology on Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial.
Lim SL; Johal J; Ong KW; Han CY; Chan YH; Lee YM; Loo WM
JMIR Mhealth Uhealth; 2020 Apr; 8(4):e14802. PubMed ID: 32281943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
